Kangji Medical (09997): Weijing Medical's four-arm surgical robot obtained registration approval

According to Zhitong Finance App, Kangji Medical (09997) announced that on April 21, 2025, Hangzhou Weijing Medical Robotics Co., Ltd. (Weijing Medical), a subsidiary of the Group, obtained registration approval from the State Drug Administration for its self-developed four-arm endoscopic surgery robot (four-arm surgical robot). Approved clinical applications include endoscopic surgery in urology, gynecology, and general surgery.

Weijing Medical's four-arm surgical robot uses an immersive 3D full HD display solution to provide surgeons with a three-dimensional vision, which helps fine tissue identification. The product is equipped with a highly flexible robotic arm that supports accurate positioning and operation. With self-developed key algorithms, it not only realizes instant mapping of master/slave operations, but also effectively filters out physiological tremor interference. This technology improves surgical safety, reduces surgeons' operating fatigue, and further optimizes surgical efficiency.

By investing in Weijing Healthcare, the Group established a robotic platform for endoscopic surgery. As of the date of this announcement, the Group directly held approximately 41.99% of Weijing Medical's shares and confirmed its performance according to the Group's shareholding ratio in consolidated financial statements. The Group plans to use its rich sales and distribution resources, as well as its experience and capabilities in manufacturing, clinical trials and regulatory matters in China to support the development and commercialization of Weijing Medical's surgical robots.

The registration application for the four-arm surgical robot was approved by the State Drug Administration, marking an important stage in the commercialization process of Weijing Healthcare and a landmark in the development of corporate strategy. As a leading enterprise in the field of minimally invasive surgery in China, the Group not only has a complete product portfolio of minimally invasive surgical instruments and consumables, but has also established an efficient and stable production and supply system. In recent years, endoscopic surgery robots have also been deployed in a forward-looking manner. Through strategic investment, Weijing Medical has built deep collaboration, continuously enhanced the core competitiveness of the enterprise, and further consolidated the Group's advantages in the field of minimally invasive surgery.